首页/数据集/Drug Availability Gap in Lebanon Compared to the FDA (2014–2024).

Drug Availability Gap in Lebanon Compared to the FDA (2014–2024).

Figshare2025-12-26 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/_p_Drug_Availability_Gap_in_Lebanon_Compared_to_the_FDA_2014_2024_p_/30955162 数据链接链接失效反馈

官方服务：

资源简介：

Drug Availability Gap in Lebanon Compared to the FDA (2014–2024).

应用场景：

创建时间：

2025-12-26

药物可及性

合理用药

Abstract We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System - SUS. This is a descri

DataCite Commons2023-04-15 更新80

Key barriers and facilitators shaping access to benznidazole (BNZ) in the United States.

药物可及性

查加斯病治疗

Key barriers and facilitators shaping access to benznidazole (BNZ) in the United States.

NIAID Data Ecosystem50

Reported Reasons for Not Obtaining Pills by Locale of Participant.

药物可及性

区域健康差异

Reported Reasons for Not Obtaining Pills by Locale of Participant.

NIAID Data Ecosystem30

Number of selected essential medicines for diabetes on NEMLs in different geographical regions and across different income levels.

糖尿病药物政策

药物可及性

*: p values were 0.386, 0.663, 0.865 across different WHO regions and 0.008, 0.008, 0.018 across different income levels for the number of essential medicines for diabetes, number of “Insulin and anal

Figshare2015-12-02 更新60

The relative risk (RR), 95% confidence interval (CI), and p-values for the availability of essential medicines for CVD obtained using Poisson regression model, the 2014 and 2017 Bangladesh Health Facility Survey (BHFS).

药物可及性

卫生设施调查统计分析

NIAID Data Ecosystem40